Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fritsche

Showing results (21-30 of 214) with videos related to

Pageof 22
Sort By:
FEMS Microbiology Letters|October 14, 1998
Enhancement of in vitro cytopathogenicity by Acanthamoeba spp. following acquisition of bacterial endosymbiontsT R Fritsche, D Sobek, R K Gautom
HNO|February 3, 2017
[Relationship between functional endoscopy and impedance-pH measurement. German version]F Michel, T Stroh, R Fritsche, et al.
Scandinavian Journal of Immunology|January 1, 1981
Immunoprecipitation of the solubilized membrane receptor for IgE of human cultured lymphoblastoid cellsR Fritsche, G C Meinke, H L Spiegelberg
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniaeRonald N Jones, Thomas R Fritsche, Helio S Sader
Antimicrobial Agents and Chemotherapy|January 9, 2008
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureusHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance ProgramLalitagauri M Deshpande, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 12, 2004
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patientsH S Sader, T R Fritsche, R N Jones
Journal of Clinical Microbiology|May 5, 2006
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003)Shawn A Messer, Ronald N Jones, Thomas R Fritsche
Antimicrobial Agents and Chemotherapy|June 25, 2008
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
Pageof 22

Showing results (21-30 of 214) with videos related to

Sort By:
Pageof 22
FEMS Microbiology Letters|October 14, 1998
Enhancement of in vitro cytopathogenicity by Acanthamoeba spp. following acquisition of bacterial endosymbiontsT R Fritsche, D Sobek, R K Gautom
HNO|February 3, 2017
[Relationship between functional endoscopy and impedance-pH measurement. German version]F Michel, T Stroh, R Fritsche, et al.
Scandinavian Journal of Immunology|January 1, 1981
Immunoprecipitation of the solubilized membrane receptor for IgE of human cultured lymphoblastoid cellsR Fritsche, G C Meinke, H L Spiegelberg
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniaeRonald N Jones, Thomas R Fritsche, Helio S Sader
Antimicrobial Agents and Chemotherapy|January 9, 2008
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureusHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance ProgramLalitagauri M Deshpande, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 12, 2004
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patientsH S Sader, T R Fritsche, R N Jones
Journal of Clinical Microbiology|May 5, 2006
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003)Shawn A Messer, Ronald N Jones, Thomas R Fritsche
Antimicrobial Agents and Chemotherapy|June 25, 2008
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
Pageof 22